Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $177.96 million. The enterprise value is $90.80 million.
| Market Cap | 177.96M |
| Enterprise Value | 90.80M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 107.21 million shares outstanding. The number of shares has increased by 4.73% in one year.
| Current Share Class | 107.21M |
| Shares Outstanding | 107.21M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +5.35% |
| Owned by Insiders (%) | 4.01% |
| Owned by Institutions (%) | 49.04% |
| Float | 102.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.73 |
| Forward PS | 8.32 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.27.
| Current Ratio | 6.49 |
| Quick Ratio | 6.36 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.27% and return on invested capital (ROIC) is -42.30%.
| Return on Equity (ROE) | -78.27% |
| Return on Assets (ROA) | -36.84% |
| Return on Invested Capital (ROIC) | -42.30% |
| Return on Capital Employed (ROCE) | -85.89% |
| Weighted Average Cost of Capital (WACC) | 14.58% |
| Revenue Per Employee | $103,454 |
| Profits Per Employee | -$1.07M |
| Employee Count | 97 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -550,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.78% in the last 52 weeks. The beta is 2.28, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.28 |
| 52-Week Price Change | -7.78% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 52.33 |
| Average Volume (20 Days) | 1,084,283 |
Short Selling Information
The latest short interest is 11.64 million, so 10.86% of the outstanding shares have been sold short.
| Short Interest | 11.64M |
| Short Previous Month | 11.59M |
| Short % of Shares Out | 10.86% |
| Short % of Float | 11.31% |
| Short Ratio (days to cover) | 6.69 |
Income Statement
In the last 12 months, CRBU had revenue of $10.04 million and -$103.40 million in losses. Loss per share was -$1.08.
| Revenue | 10.04M |
| Gross Profit | -73.82M |
| Operating Income | -107.20M |
| Pretax Income | -103.95M |
| Net Income | -103.40M |
| EBITDA | -104.61M |
| EBIT | -107.20M |
| Loss Per Share | -$1.08 |
Balance Sheet
The company has $112.31 million in cash and $26.66 million in debt, with a net cash position of $87.16 million or $0.81 per share.
| Cash & Cash Equivalents | 112.31M |
| Total Debt | 26.66M |
| Net Cash | 87.16M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 98.10M |
| Book Value Per Share | 0.93 |
| Working Capital | 98.62M |
Cash Flow
In the last 12 months, operating cash flow was -$95.78 million and capital expenditures $28,000, giving a free cash flow of -$95.75 million.
| Operating Cash Flow | -95.78M |
| Capital Expenditures | 28,000 |
| Depreciation & Amortization | 2.59M |
| Net Borrowing | n/a |
| Free Cash Flow | -95.75M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,068.22% |
| Pretax Margin | -1,035.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -58.10% |
| FCF Yield | -53.80% |
Analyst Forecast
The average price target for CRBU is $11.86, which is 614.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.86 |
| Price Target Difference | 614.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 45.96% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -5.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.47 |
| Piotroski F-Score | 3 |